1.Financial Impact of Supply Chain Normalization
Metric cards and line chart · 2026
This equity research dashboard presents a comparative fundamental analysis of Novartis, UBS, and Logitech across a five-year period from FY2021 to FY2026. The analysis highlights Novartis for having the steadiest revenue base with 5.3% revenue-growth volatility and a 32.4% operating margin, while UBS shows the highest balance-sheet sensitivity with leverage at 17.9x compared to Novartis at 2.38x and Logitech at 1.74x. Logitech demonstrates a supply-chain normalization angle with +6.3% latest revenue growth, illustrating how macroeconomic flow metrics influence an allocation implication of NVS > LOGI > UBS.
What it shows:
How to model fundamental metrics and revenue trends to assess supply chain normalization impacts.




